ORPHA:108
Babesiosis
Publications
12,365
Trials
3
Interventional, condition-specific
Researchers
1,195
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Babesiosis is an infectious disease caused by protozoa of the genus Babesia and characterized by a febrile illness and hemolytic anemia but with manifestations ranging from an asymptomatic infection to a fulminating illness that can result in death.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0005661
- MeSH:D001404
- UMLS:C0004576
- NCIT:C84581
Additional Mondo synonyms (6)
Babesia caused disease or disorder · Babesia disease or disorder · Babesia infectious disease · babesiasis · infection by Babesia · piroplasmosis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
12,365 matched papers (6,003 in last 10 years) Source
- Phenotype characterisedPresent
33 HPO annotations (e.g. Decreased total leukocyte count; Anorexia; Hepatomegaly) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
3 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
33
Associated phenotypes · MONDO:0005661
- Decreased total leukocyte count
- Anorexia
- Hepatomegaly
- Headache
- Arthralgia
Showing 5 of 33 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
CTD chemicals (MyDisease.info)
2 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- diminazene aceturate · therapeutic
- Pentamidine · therapeutic
Literature
Is anyone studying this?
12,365
12,365 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
12,365 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
6,003 in the last 10 years · low confidence
Phrase hits: 12,365 · MeSH hits: 0
Who's working on it?
1,195
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Zhang Y7 papers · 2026
Parasitology Laboratory, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.
Papers in Europe PMC - 02
- 03Yokoyama N6 papers · 2026
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan; WOAH Reference Laboratories for Bovine Babesiosis and Equine Piroplasmosis, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan. Electronic address: yokoyama@obihiro.ac.jp.
Papers in Europe PMC - 04
- 05Suarez CE5 papers · 2026
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America.
Papers in Europe PMC - 06Bastos RG4 papers · 2026
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America.
Papers in Europe PMC - 07Cai Y4 papers · 2026
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Shanghai, People's Republic of China.
Papers in Europe PMC - 08Elsawy BSM4 papers · 2026
Department of Parasitology and Animal Diseases, Veterinary Research Institute, National Research Centre, Donkki, Giza 12622, Egypt.
Papers in Europe PMC - 09Kumar S4 papers · 2026
ICAR-National Research Centre on Equines, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana 125004 India.
Papers in Europe PMC - 10Martínez E4 papers · 2026
Gasset Laboratory, DAV Salud Group SL, 18200 Granada, Spain.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
3
interventional trials for this specific condition
3 interventional trials matched this specific condition name; 2 currently recruiting in our sample.
Data as of 11 September 2026
3 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 86.7th percentile).
low confidence · 86.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
3 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06207370·RECRUITING·Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Not reviewed·Conditions: Babesiosis·Matched via name phrase
- NCT06656351·RECRUITING·B-FREE Chronic Babesiosis Study
Not reviewed·Conditions: Chronic Babesiosis·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07345988·RECRUITING·Human Babesiosis in Metropolitan France
Not reviewed·Conditions: Human Babesiosis·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (2)
- isrctn·ISRCTN48548060·No longer recruiting·Evaluation of the GRI gentleheel® device for adult finger blood sampling
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65689096·No longer recruiting·Comparison of two techniques for collecting umbilical cord blood: on the mother (upper level) versus on the delivery table (bottom level)
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Babesiosis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Babesiosis" OR "Babesia infectious disease" OR "babesiasis" OR "infection by Babesia" OR "piroplasmosis")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Babesiosis" OR "Babesia infectious disease" OR "babesiasis" OR "infection by Babesia" OR "piroplasmosis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 3 interventional · 2 observational · 1 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: Babesia caused disease or disorder; Babesia disease or disorder
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (12365) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T12:27:00.222Z
